We also highlighted that loss of CPB1 in DCIS could switch the cell phenotypes to be more invasive by the loss of the tumor suppressor gene SFRP1 and OS9 (inhibitor of HIF1α). This evidence concerns the gene SFRP1 and ductal breast carcinoma in situ.